MedTrace Logo

Burden and Medical Care of Sarcoma in Germany

NCT03521531 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1309

Last updated 2021-08-27

No results posted yet for this study

Summary

The main objective of the study is to assess the treatment situation of sarcoma patients in Germany and to investigate their potential influence on Quality of Life (and other Patient Reported Outcomes) of the affected persons. Impaired quality of life domains and factors associated with it are to be identified.

To this end, a national network of sarcoma treatment specialists and a structure for patient recruitment will be established. This care network is intended to reflect the current situation of the treatment of sarcoma patients in Germany.

Conditions

  • Sarcoma

Sponsors & Collaborators

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Markus Schuler, MD · Technical University Dresden, Medical Faculty

  • Jochen Schmitt, PhD · Technical University Dresden, Medical Faculty

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-30
Primary Completion
2019-11-01
Completion
2021-07-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03521531 on ClinicalTrials.gov